Royce & Associates’s Kymera Therapeutics KYMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.47M	Buy	+33,797	New	+$1.47M	0.02%	636
2024 Q2	–	Sell	-7,076	Closed	-$284K	–	897
2024 Q1	$284K	Sell	7,076 -8,928	-56%	-$359K	﹤0.01%	819
2023 Q4	$407K	Buy	+16,004	New	+$407K	﹤0.01%	802